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Immunology, Faculty of Medicine, University of Geneva, Geneva, SwitzerlandABSTRACT RANTES (CCL5) is a chemokine that recruits immune cells to inflammatory sites by interacting with the G-protein
coupled receptor CCR5, which is also the primary coreceptor used together with CD4 by HIV to enter and infect target cells.
Ligands of CCR5, including chemokines and chemokine analogs, are capable of blocking HIV entry, and studies of their struc-
tures and interactions with CCR5 will be key to understanding and optimizing HIV inhibition. The RANTES derivative 5P12-
RANTES is a highly potent HIV entry inhibitor that is being developed as a topical HIV prevention agent (microbicide). We
have characterized the structure and dynamics of 5P12-RANTES by solution NMR. With the exception of the nine flexible
N-terminal residues, 5P12-RANTES has the same structure as wild-type RANTES but unlike the wild-type, does not dimerize
via its N-terminus. To prepare the ground for interaction studies with detergent-solubilized CCR5, we have also investigated the
interaction of RANTES and 5P12-RANTES with various commonly used detergents. Both RANTES variants are stable in
Cymal-5, DHPC, Anzergent-3-12, dodecyltrimethylammonium chloride, and a DDM/CHAPS/CHS mixture. Fos-Cholines,
dodecyldimethylglycine, and sodium dodecyl-sulfate denature both RANTES variants at low pH, whereas at neutral pH the
stability is considerably higher. The onset of Fos-Choline-12-induced denaturation and the denatured state were characterized
by circular dichroism and NMR. The detergent interaction starts below the critical micelle concentration at a well-defined mixed
hydrophobic/positive surface region of the chemokine, which overlaps with the dimer interface. An increase of Fos-Choline-12
concentration above the critical micelle concentration causes a transition to a denatured state with a high a-helical content.INTRODUCTIONRANTES (CCL5) belongs to the class of chemokines
(chemotactic cytokines), i.e., small (8–10 kDa) soluble
secreted proteins that regulate immune responses by attract-
ing various immune cell types to sites of inflammation.
Based on the arrangement of conserved N-terminal cyste-
ines, chemokines are divided into four subclasses: C, CC,
CXC, and CX3C (1). Chemokines signal by interacting
with G protein-coupled receptors, which are named accord-
ing to the chemokine subclass they interact with and a num-
ber, e.g., CCR5, CXCR4, etc. (2).
The fact that the CC chemokines RANTES, MIP-1a, and
MIP-1b can suppress HIV infection, with RANTES being
the most effective (3), has made RANTES an interesting
candidate as an HIV entry inhibitor. This discovery was
followed by the identification of the respective chemokine
receptor CCR5, which binds all three of these ligands, and
also functions as the principal HIV-1 coreceptor (4).
Depending on concentration, RANTES is known to signal
via two distinct pathways (5): at low RANTES concentra-
tions (%50 nM), a Gai-type GPCR pathway regulates
chemotaxis and transient calcium mobilization, whereas
higher RANTES concentrations (R1 mM) cause general
T cell activation via protein tyrosine kinases (6,7). Interest-
ingly, high concentrations of RANTES enhance viral infec-
tion instead of inhibiting it (8).Submitted August 8, 2013, and accepted for publication October 28, 2013.
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0006-3495/13/12/2586/12 $2.00RANTES and other chemokines can form dimers, higher-
order oligomers, and large molecular-weight aggregates
(9,10). Wild-type RANTES is particularly aggregation-
prone (10), and this property correlates with inflammation
(11). Key residues involved in oligomerization are E26
and E66, because the charge-neutralizing E26A and E66S
mutations suppress formation of very high molecular weight
aggregates and lead predominantly to tetrameric and
dimeric RANTES, respectively (12). Although such
disaggregated RANTES mutants retain CCR5-binding and
Gai-dependent signaling properties, they fail to activate
the protein tyrosine kinase pathway and do not activate T
lymphocytes, neutrophils, and monocytes (11).
Structures of numerous chemokines including RANTES,
MIP-1a, MIP-1b, vMIP-II, and SDF-1a have been solved
by x-ray crystallography and NMR (12–20). Their tertiary
structures are highly conserved (Fig. 1): the first two cyste-
ines (C9 and C10 for RANTES) delimit the often flexible N-
terminus and form disulphide bonds with cysteines in the
center (30s loop) and the C-terminus (50s loop). The
N-terminal cysteines are followed by a single-turn 310-helix,
three b-strands, and a C-terminal a-helix (22). Although the
tertiary structures are highly conserved, the quaternary
homo-oligomeric structures vary strongly (22). Thus the
CCR5 ligands, i.e., RANTES, MIP-1a, MIP-1b, and
vMIP-II dimerize via an intermolecular N-terminal antipar-
allel b-sheet involving the first cysteine and two preceding
residues (PDB:1EQT, PDB:2X6G, PDB:2X6L, and
PDB:1CM9), whereas the CXCR4 ligand SDF-1a dimerizeshttp://dx.doi.org/10.1016/j.bpj.2013.10.025
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FIGURE 1 Cartoon representation of the crystal structure of the
RANTES dimer (PDB:1EQT) highlighting secondary structure elements:
a-helix (green), 310-helix (purple), b-strand (cyan), b-turn (orange), and
random coil (gray). The four cysteines are shown (in yellow), and the res-
idues involved in RANTES aggregation (E26 and E66, in red). The
RANTES dimer is stabilized by an intermolecular b-sheet formed by the
N-termini. The figure was generated using the software VMD (75). To
see this figure in color, go online.
Characterization of 5P12-RANTES 2587via an extended structural motif comprising the C-terminal
a-helix and the first b-strand (PDB:1A15).
Dimer formation and interactions with peptides from the
N-terminal tail of CCR5 have been studied in detail by
NMR (23). RANTES monomer and dimer are in slow
exchange and can be observed as separate sets of 1H-15N
HSQC resonances, yielding a dissociation constant of the
RANTES monomer-dimer equilibrium of 17.6 mM at
pH 3.8 and of 2.9 mM at pH 6.0. This indicates that the
dimeric RANTES form is more stable at higher pH. It was
also shown that an N-terminal CCR5 peptide sulfated at
Y10 and Y14 predominantly binds to monomeric RANTES
at pH 3.8 and that the interaction interface overlaps with the
interface of RANTES dimerization observed in the crystal
structure PDB:1EQT. A more recent study using a slightly
longer N-terminal CCR5 peptide at pH 4.8 showed strong
binding to the RANTES monomer (KD ¼ 16 mM), but
also weak binding (KD ¼ 100 mM) to the dimer (24).
Based on NMR, mass spectrometry, and small-angle
x-ray scattering data, a structural model of higher RANTES
oligomers has been proposed (25). In this model, tetramers
form from dimers by interactions between the second
b-strand and the C-terminal a-helix of one monomer within
a dimer with corresponding locations in a second dimer.
Because these interactions are limited to one monomer in
each dimer, the structure can propagate into long, linear
oligomers. The interdimer contacts involve hydrophobic
(residues Y27, F28, I62, and L65) and electrostatic interac-
tions (K25, E26, E66, and R44), which provides a rationale
for the reduced aggregation properties of the RANTES
E26A and E66S mutants (11,12).
Since the discovery of its HIVentry-inhibiting properties,
numerous strategies, e.g., peptide derivatives (26,27),N-terminal truncations (28–34), chemical modifications of
the N-terminus (35–38), or mutagenesis (39–41) have
been pursued to develop a topical HIV prevention agent
(microbicide) based on RANTES. The variant 5P12
(5P12-RANTES) was obtained using a phage display of
N-terminal RANTES mutants on living cells expressing
CCR5, with isolated candidates assessed not only for high
anti-HIV potency, but also low CCR5 signaling activity
(42). In 5P12-RANTES, the wild-type N-terminus S1
PYSSDTTP9 has been replaced by the more hydrophobic
amino acid sequence Q0GPPLMATQS9. 5P12-RANTES
shows very high anti-HIV potency (28 nM) and does not
activate CCR5. Hence, it carries a lower risk of unwanted
inflammatory side effects that could be elicited by wild-
type RANTES (wt-RANTES) or highly potent analogs
with agonist activity such as PSC-RANTES (43). As a fully
recombinant chemokine analog, 5P12-RANTES has the
potential to be produced economically by using low-cost
fermentation approaches (42), and shows suitable stability
for use as a microbicide (44). Based on its promising
profile, 5P12-RANTES has been taken forward into clinical
development (Oliver Hartley, personal communication,
2013).
Here, we have characterized the structure, dynamics, and
oligomeric state of 5P12-RANTES (in the reduced aggrega-
tion form 5P12-RANTES-E66S) by solution NMR and
circular dichroism (CD) spectroscopy and compared these
properties to wt-RANTES and RANTES-E66S. In addition,
we have screened various commonly used detergents for
interactions with 5P12-RANTES-E66S and RANTES-
E66S to prepare the ground for in vitro interaction studies
with detergent-solubilized receptors.MATERIAL AND METHODS
Cloning, expression, and purification
The DNA sequence of 5P12-RANTES-E66S DNA was obtained by
mutating the previously described GB1-RANTES-E66S construct inside
the pGEV2 plasmid (23) to a GB1-5P12-RANTES-E66S construct. The
GB1-5P12-RANTES-E66S and GB1-RANTES-E66S fusions are cleavable
by the blunt-cutting enterokinase, releasing 5P12-RANTES-E66S and
RANTES-E66S, respectively, without additional amino acids at their
N-termini. The cloning strategy (see Fig. S1 in the Supporting Material)
used three consecutive site-directed mutagenesis PCR steps with the
following primer pairs:
1. 50-GATCCGACGACGACGACAAGCAG-GGCCCATATTCCTCGGA
CACC-30 and 50-GGTGTCCGAGGAATATGGGCCCTGCTTGTCGTC
GTCGTCGGATC-30;
2. 50-CCCATATTCCTCGGACACCCAATCCTGCTGCTTTGCCTACAT
TG-30 and 50-CAATGTAGGCAAAGCAGCAGGA-TTGGGTGTCCG
AGGAATATGGG-30;
3. 50-GACGACAAGCAGGGCCCACCTTTAATGGCCACCCAATCCTG
CTGC-30 and 50-GCAGCAGGATTGGGTGGCCATTAAAGGTGGGC
CCTGCTTGTCGTC-30.
Each PCR step changed 3–7 nucleotides resulting in a mutation of 2–4
amino acids. Before proceeding to the next step, the plasmid was amplified
in self-prepared TOP10 cells followed by gene sequencing to screen forBiophysical Journal 105(11) 2586–2597
2588 Wiktor et al.the correctly mutated clones. Isotopically labeled RANTES-E66S and
5P12-RANTES-E66S were expressed and purified as described in Duma
et al. (23).CD spectroscopy
CD spectra were recorded on 25–60 mM RANTES-E66S/5P12-RANTES-
E66S samples under various conditions specified in the figure legends.
Measurements were performed on a Chirascan CD spectrometer (Applied
Photophysics, Leatherhead, UK) at 9–94C in a 1-mm quartz Suprasil
cuvette (Hellma, Mu¨llheim, Germany). Data points in a wavelength range
of 204–260 nm were collected every 1 nm (bandwidth 1 nm) and averaged
for 3 s. For thermal denaturation, the temperature was increased in 2C
increments, allowing 60 s equilibration after reaching the set value
(0.5C tolerance). Accurate temperature readings were obtained from a
sensor placed in the sample cuvette. After baseline (buffer spectra) subtrac-
tion, the mean residue molar ellipticity QMRM was calculated as QMRM ¼
Q/(C  n  l), where Q is the ellipticity, C is the concentration, n is the
number of residues, and l is the optical path length. For thermal melts,
sigmoidal two-state denaturation curves that included sloping baselines
(45,46) and DG expressed in terms of DH, DCp, and melting temperature
Tm (47) were fitted using PRO FIT 6.2.9 (Quantum Soft, Uetikon Am
See, Switzerland).Sample preparation for NMR
Samples without detergent contained 0.6 mM 15N/13C-labeled 5P12-
RANTES-E66S, 50 mM KH2PO4, 0.02% NaN3, pH 3.8, 5% D2O. Unless
noted otherwise, samples containing the detergent Fos-Choline-12 (FC-
12, dodecylphosphocholine) contained 0.25 mM 15N/13C-labeled 5P12-
RANTES-E66S or 50 mM 2H/15N/13C-labeled RANTES-E66S, 50 mM
DCOONa, 0.02% NaN3, 1% (28 mM) FC-12, pH 3.8, 5% D2O. Samples
for screening of other detergents by 1H-15N HSQC spectra typically con-
tained 50 mM 15N-labeled protein, 1% detergent, and 50 mM DCOONa
pH 3.8 (5P12-RANTES-E66S/RANTES-E66S) or 50 mM CD3COONa
pH 4.7 (ubiquitin). Detergents were obtained from Anatrace, Maumee,
OH. A full list of the used detergents together with their chemical structures
and several physicochemical properties is given in Table S1 in the Support-
ing Material and a full list of tested conditions is given in Table 1.Backbone assignment
All NMR experiments were recorded on either a DRX600 spectrometer
equipped with a triple resonance, triple-axis gradient TXI probe or a
DRX800 spectrometer with a triple resonance, Z-gradient TCI cryoprobe
(Bruker, Billerica, MA). The following three-dimensional spectra were
used for assignment of backbone resonances in the different samples:
CBCANH, HNCO (5P12-RANTES-E66S, 37C);
CBCANH (5P12-RANTES-E66S, 1% FC-12, 25C);
CBCANH, CBCACONH, HNCO (5P12-RANTES-E66S, 1% FC-12,
60C);
HNCACB (RANTES-E66S, 1% FC-12, 25C).
NMR spectra were processed using the software NMRPIPE (48) and eval-
uated with the software SPARKY (49).FIGURE 2 1H-15N HSQC spectrum of 0.6 mM 15N/13C-labeled 5P12-
RANTES-E66S (50 mMKH2PO4, 0.02% NaN3, pH 3.8, 5% D2O) recorded
at 37C on a 600-MHz spectrometer. Backbone amide resonances are
labeled with the assignments. The N-terminal glutamine Q0 undergoes a
spontaneous cyclization to pyroglutamate (mechanism shown in the inset)
resulting in the appearance of Q0 resonance and a shift of the G1 resonance
from G1f to G1c (marked by arrow) corresponding to the free and the cyclic
N-terminus, respectively.Chemical-shift analysis
The 1H chemical shift was referenced relative to DSS using the frequency
of the water resonance as described in Vajpai et al. (50), while the chemical
shifts of 13C (relative to DSS) and 15N (relative to NH3) were referenced
indirectly from the obtained 1H DSS frequency (51). Chemical shifts of
the RANTES-E66S dimer were taken from BMRB entry No. 16803. Sec-Biophysical Journal 105(11) 2586–2597ondary shifts were calculated by subtraction of random coil shifts from
the experimental shifts. Random coil shifts (except for cystines) were ob-
tained from the web server of the University of Kopenhagen (http://
www1.bio.ku.dk/english/research/pv/sbin_lab/staff/MAK/randomcoil/
script/), which uses protein sequence, pH, and temperature corrections
(52–54), while cystine random coil shifts were obtained from the web
server of the Vendruscolo laboratory (http://www-vendruscolo.ch.cam.ac.
uk/camcoil.php) using the CAMCOIL software program (55).Relaxation experiments
Standard 15N relaxation measurements (R1 ¼ 1/T1, R2 ¼ 1/T2, {1H}-15N
nuclear Overhauser effect (NOE)) were recorded on uniformly 15N/13C-
labeled 5P12-RANTES-E66S at 600 MHz at 37C. The R1, R2 decay curves
were fitted by an in-house written routine implemented in MATLAB (The
MathWorks, Natick, MA) providing Monte Carlo estimation of errors.
NMR spectra were processed using the software NMRPIPE (48) and eval-
uated with the software PIPP (56).RESULTS AND DISCUSSION
5P12-RANTES-E66S heteronuclear backbone
assignment and aggregation state
Similarly to other chemokines, RANTES forms dimers as
well as higher-order oligomers, which makes it precipita-
tion-prone and challenging to handle in vitro (10). For these
reasons, we used the less-aggregation-prone E66S mutation
in 5P12-RANTES (11). 5P12-RANTES-E66S gives a well-
dispersed 1H-15N HSQC spectrum characteristic for folded
proteins containing b-sheets (Fig. 2). Unlike wt-RANTES
and RANTES-E66S, where monomer and dimer resonances
can be observed in slow exchange in the micro- to
ab
FIGURE 3 Secondary 13Ca (a) and 13Cb (b) chemical shifts analysis of
RANTES-E66S dimer (37C), 5P12-RANTES-E66S (37C), and 5P12-
RANTES-E66S in the presence of 1% FC-12 (at 25 and 60C).
Secondary structure elements according to the crystal structure PDB:1EQT
and the amino acid sequence of RANTES-E66S as well as of 5P12-
RANTES-E66S are drawn at the top. (Note that the sequence used in
PDB:1EQT differs from human wt-RANTES by the mutations S1M,
P2G, and L19M.) The extraordinary large secondary shifts for Q0 are the
result of the pyroglutamate formation.
Characterization of 5P12-RANTES 2589millimolar range (23), 5P12-RANTES-E66S displays only a
single set of concentration-independent resonances in this
concentration range. Furthermore, the 5P12-RANTES-
E66S resonances agree much better with the monomer
than with the dimer resonances of RANTES-E66S (see
Fig. S2). This indicates that 5P12-RANTES-E66S exists
in a single, i.e., monomeric state. This is also inferred
from the analysis of the retention volume on size-exclusion
chromatography, where RANTES-E66S elutes as 15.7 5
0.1 (standard deviation) kDa, while 5P12-RANTES-E66S
elutes as 8.5 5 0.4 kDa globular protein (see Fig. S3).
Apparently, 5P12-RANTES-E66S does not form dimers
even at millimolar concentrations, which can be explained
by the fact that residues S4-D6, T8, and P9 of the wild-type
N-terminus, which are strongly involved in intermolecular
b-sheet contacts (Fig. 1), are all mutated in 5P12-
RANTES-E66S. Accordingly, also 5P12-RANTES does
not show any indication of dimer formation in one-dimen-
sional 1H spectra (Lydia Nisius, University of Basel and
Oliver Hartley, personal communication, 2011).
Backbone assignments for 1HN, 15N, 13C0, 13Ca, and 13Cb
resonances were obtained for all nonproline residues of
5P12-RANTES-E66S from three-dimensional CBCANH
and HNCO spectra. Interestingly, the 1H-15N correlation
of the N-terminal Q0 is also detected in the HSQC spectrum.
Due to fast hydrogen exchange, this correlation of an
N-terminal NH3
þ group is usually not observable. The
observation of this correlation for Q0 is consistent with
the expected cyclization of the N-terminal 5P12-RANTES
glutamine residue (42) via a nucleophilic attack of the
backbone nitrogen lone pair on the side-chain carbonyl
carbon that results in the formation of a stable pentacyclic
pyroglutamate ring (57) with an uncharged NH group
(Fig. 2, inset). The cyclization also strongly affects the
chemical shift of the second residue G1 (Fig. 2). The reac-
tion requires deprotonated amine and therefore takes days
to complete at low pH. At the tested conditions (pH 3.8,
set of measurements at 37C interleaved with storage at
4C), the approximate half-life of the reaction was approx-
imately two days. Presumably, the increase in hydrophobic-
ity by the N-terminal cyclization is advantageous for HIV
inhibition (42), since also the efficient anti-HIV variant
PSC-RANTES (Na-(n-nonanoyl)-des-Ser1-[L-thioproline2,
L-a-cyclohexyl-glycine3]) contains highly hydrophobic
N-terminal modifications (43).Secondary structure of 5P12-RANTES-E66S
Secondary chemical shifts DdCa, DdCb (Fig. 3), DdC0, and
DdN (see Fig. S4) were obtained from the measured 13Ca,
13Cb, 13C0, and 15N shifts by subtraction of respective
random coil values. From residue F12 to the C-terminal
S66, the (secondary) chemical shifts of 5P12-RANTES-
E66S closely follow those of RANTES-E66S, which indi-
cates that in this region 5P12-RANTES-E66S should havea very similar structure to RANTES-E66S. However, larger
deviations are found in the N-terminal region before residue
F12, where RANTES-E66S dimerizes via the N-terminal
b-sheet, but 5P12-RANTES-E66S adopts a random struc-
ture as evident from close to zero secondary chemical shifts.
Furthermore, reduced secondary chemical shifts in the re-
gion L65-M67 indicate that the C-terminal helix a1 of
both RANTES-E66S and 5P12-RANTES-E66S is three
residues shorter in solution than in the PDB:1EQT crystalBiophysical Journal 105(11) 2586–2597
2590 Wiktor et al.structure (Fig. 3, top). This can be explained by crystal con-
tacts between the end of helix a1 (residues E66–S68) and
residues P20, H23, and R47 of neighboring molecules,
which apparently stabilize the helix end by electrostatic
and hydrophobic interactions.5P12-RANTES-E66S dynamics
The dynamics of 5P12-RANTES-E66S in solution was
characterized by 15N relaxation experiments (R1, R2,
{1H}-15N NOE, Fig. 4). The core of 5P12-RANTES-E66S
(residues C10-N63, excluding Y14 and G32, which are
affected by exchange broadening) has very uniform R1,
R2, and {
1H}-15N NOE values of 2.26 5 0.13 s1,
6.08 5 0.78 s1, and 0.71 5 0.04, respectively. These
values correspond to a well-folded protein core tumbling
with an isotropic rotational correlation time of 4.0 ns, which
is somewhat larger than the 3.1 ns expected for a rigid
isotropic rotator of 7.9 kDa at 37C. Possibly, this increase
is caused by the onset of aggregation at the used 0.6 mM
concentration.
In contrast to the core, the N-terminal residues Q0–S9 and
C-terminal residues beyond approximately N63 show
strongly reduced R1 and {
1H}-15N NOE values indicative
of large amplitude motions in the pico- to nanosecond range
from terminal fraying. In addition, increased R2 values for
residues M5-S9 give evidence of further slow micro- to
millisecond motion in this region. The high mobility of
the N-terminal region preceding cysteines (Q0–S9) is inFIGURE 4 15N R1, R2, and {
1H}-15N NOE relaxation data recorded on
0.6 mM 15N/13C-labeled 5P12-RANTES-E66S at 37C on a 600-MHz
spectrometer. The data are an average of two (R1 and {
1H}-15N NOE) or
three (R2) independent experiments with error bars representing standard
deviations. Secondary structure elements and the amino acid sequence of
5P12-RANTES-E66S are drawn at the top.
Biophysical Journal 105(11) 2586–2597agreement with the monomeric state of 5P12-RANTES-
E66S, which, in contrast to the wild-type, does not form
an intermolecular b-sheet via its N-terminus.Interactions of RANTES with Fos-Choline-12
In vitro studies of GPCR ligand interactions are often car-
ried out with detergent-solubilized receptors. The suitability
of a detergent is usually judged based on the activity of the
solubilized receptor, e.g., efficiency of binding a soluble
ligand. Absence of activity is then often ascribed to unfavor-
able effects of detergent on the receptor and less attention is
given to effects on the ligands. In an effort to find a suitable
detergent for RANTES CCR5 interaction studies, we have
screened several detergents for their effects on RANTES.
A list of all investigated detergents together with their chem-
ical structure and other physiochemical parameters like the
critical micelle concentration (CMC) is shown in Table S1.
FC-12 solubilizes CCR5 very efficiently (58,59). How-
ever, only very little or no ligand binding has been observed
in surface plasmon resonance experiments (60). Thus we
sought to test its interactions with RANTES. Size exclusion
chromatography (Superdex 200 10/300 GL; GE Healthcare,
Little Chalfont, UK) shows that 5P12-RANTES-E66S in the
presence of 0.5% FC-12 elutes much earlier (Fig. 5 a,
10.7 mL) than in its absence (16.2 mL). This indicates a
major increase in molecular mass (to R36 kDa as judged
based on the column calibration in Fig. S3), suggesting a
direct interaction of 5P12-RANTES-E66S and FC-12.Structural analysis of RANTES in Fos-Choline-12
Possible effects of FC-12 on the RANTES structure were
first examined by CD spectroscopy (Fig. 5 b). Without
detergent, the RANTES-E66S CD spectrum has a maximum
at 232 nm and a shallow minimum at 207 nm, which reflects
its mixed secondary structure consisting of a/310 helices,
b-sheet, and the flexible N-terminus (Fig. 4). Upon addition
of 0.5% FC-12 at pH 3.8, the ellipticity strongly decreases,
consistent with a conversion to a more helical secondary
structure. Similar observations were made for 5P12-
RANTES-E66S (see Fig. S5, d and f). At pH 7.7, however,
the spectra with and without detergent are very similar, indi-
cating that at the higher pH, FC-12 does not have a pro-
nounced effect on the RANTES-E66S secondary structure
(Fig. 5 b).
Subsequently, a more detailed NMR structural analysis
was carried out on 5P12-RANTES-E66S in FC-12. Only
about a dozen backbone resonances are visible in the
1H-15N HSQC spectrum of 5P12-RANTES-E66S in 0.5%
FC-12 at 25C and pH 3.8 (Fig. 6 a), most of which could
be assigned by a CBCANH experiment. The resonances
correspond to the apparently flexible N- (Q0, G1, L4, M5,
A6, T7) and C-terminal (I62, N63, S64, L65, S66, M67,
S68) residues. Other residues from the core of the molecule
ab
FIGURE 5 (a) Size exclusion chromatogram of 5P12-RANTES-E66S
with (dashed line) and without (solid line) 0.5% FC-12 performed on a
Superdex 75 10/300 GL column (GE Healthcare) in 50 mM HCOOH
pH 3.8 at room temperature and 0.5 mL/min flow rate. The large decrease
of the retention volume (from 16.2 to 10.7 mL) resulting from a major
increase of mass (to R36 kDa) suggests a direct interaction between
5P12-RANTES-E66S and FC-12. (b) pH-dependent effect of detergent
on RANTES-E66S secondary structure measured by CD spectroscopy at
25C. The spectrum of RANTES-E66S at pH 3.8 without detergent (solid
line) changes dramatically after addition of 0.5% FC-12 (dashed line).
However, at pH 7.7, the spectra without detergent (dotted line) and after
addition of 0.5% FC-12 (dashed-dotted line) are very similar.
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FIGURE 6 1H-15N HSQC spectra of 0.25 mM 15N/13C-labeled 5P12-
RANTES-E66S in the presence of 1% FC-12 (50 mM KH2PO4, 0.02%
NaN3, pH 3.8, 5% D2O) recorded at 25
C (a) and at 60C (b) on a 600-
MHz spectrometer. Backbone amide resonances are labeled with assign-
ment information. At 25C, only terminal residues are visible. An increase
to 60C causes most of the resonances to reappear. Compared to the spec-
trum in Fig. 2, the presence of FC-12 reduces 5P12-RANTES-E66S peak
dispersion from >4 to only ~1 ppm, suggesting a significant change in
the secondary structure.
Characterization of 5P12-RANTES 2591are undetectable. This can be caused by strong interactions
of the core residues with the large detergent micelle or also
by conformational exchange on the intermediate timescale.
An increase in temperature from 25 to 60C (Fig. 6 b) leads
to the reappearance of most resonances from the core resi-
dues. Analogous observations were made for RANTES-
E66S at both 25 and 60C (see Fig. S6, f and g).
The HSQC spectrum of 5P12-RANTES-E66S/RANTES-
E66S in 0.5% FC-12 at 60C shows a strongly reduced
dispersion as compared to the spectra without detergent at
25C (Fig. 2) and at 60C (see Fig. S6 b) representing the
folded protein. This is consistent with the loss of native
b secondary structure in favor of a and/or random coil
conformations and hence with the CD data. The majority
of backbone resonances of 5P12-RANTES-E66S in FC-12
at 60C could be assigned by a set of CBCANH,
CBCACONH, and HNCO experiments. Their secondary
chemical shift analysis (Figs. 3 and see Fig. S4) reveals a
severe structural perturbation by FC-12. The only preserved
secondary structure segment is helix a1, which, however, is
four residues longer (52–64 instead of 56–64) in FC-12. Allindications of b-structure (negative DdCa and DdC0) are lost
for all b-strands. Instead, positiveDdCa and DdC0 of ~1 ppm
in the regions of residues P20-Y29 and P37-R44 indicate the
appearance of ~25% a-helical populations. Analysis of the
secondary chemical shifts at 25C confirms a similar
secondary structure as at 60C for the few detectable termi-
nal residues for 5P12-RANTES-E66S (Fig. 3) and
RANTES-E66S (see Fig. S7).Interactions of RANTES with other detergents
To investigate the specificity and mechanism of the
RANTES detergent interaction, we have tested a series of
detergents for their effects on 1H-15N HSQC spectra of
RANTES-E66S and 5P12-RANTES-E66S at several tem-
peratures and pH values. The results are summarized in Ta-
ble 1 and corresponding spectra are shown in Fig. S6.
Members of the Fos-Choline family with a shorter (FC-
10) and with a longer (FC-16) hydrocarbon tail caused a
very similar effect to FC-12 (see Fig. S6, e and h): RANTES
is in an NMR dark state with only a dozen resonances visible
at 25C. Interestingly, the C-terminus experienced larger
chemical shift changes by the variation of the hydrocarbon
tail length than the N-terminus (see Fig. S8). This may indi-
cate that the RANTES C-terminus interacts more strongly
with the hydrophobic part of the detergent. However, the
addition of 1% FC-8 did not change the RANTES spectrum.
Only at 5% FC-8 were the RANTES resonances partiallyBiophysical Journal 105(11) 2586–2597
TABLE 1 Protein state perturbation by detergents
No. Proteina pHb Temp [C] Detergentc [Detergent]/[CMC] Protein state
1 RANTES-E66S 3.8 25 — — Folded, ID < IM
d
2 RANTES-E66S 3.8 60 — — Onset of thermal unfolding
3 RANTES-E66S 3.8 25 1% FC-8 0.3 Folded, ID > IM
4 RANTES-E66S 3.8 25 5% FC-8 1.5 Folded and denatured in slow exchange
5 RANTES-E66S 3.8 25 1% FC-10 2.9 Denatured, only terminal residues visible
6 RANTES-E66S 3.8 25 1% FC-12 21 Denatured, only terminal residues visible
7 RANTES-E66S 3.8 60 1% FC-12 21 Denatured, most residues visible
8 RANTES-E66S 3.8 25 1% FC-16 1881 Denatured, only terminal residues visible
9 RANTES-E66S 3.8 25 5% DHPC 75 Folded, ID > IM
10 RANTES-E66S 3.8 25 1% ANZ 3-12 11 Folded, ID > IM
11 RANTES-E66S 3.8 25 1% TMA-12 1.9 Folded, ID > IM
12 RANTES-E66S 3.8 25 1% DMG-12 24 Folded and (mostly) denatured in slow exchange
13 RANTES-E66S 3.8 49 1% DMG-12 24 Denatured, most residues visible
14 RANTES-E66S 3.8 25 1% SDS 4.3 Denatured, only terminal residues visible
15 RANTES-E66S 3.8 25 1% Cymal-5 8.3 Folded, ID z IM
16 RANTES-E66S 3.8 25 1% DDM, 12 Folded, ID z IM
1% CHAPS, 2.0
0.2% CHS N/A
17 RANTES-E66S 6.3 25 1% FC-12 21 Folded and denatured in slow exchange
18 RANTES-E66S 8.8 25 — — Folded, only dimer resonances visible
19 RANTES-E66S 8.8 25 1% FC-12 21 Folded, only dimer resonances visible
20 5P12-RANTES-E66S 3.8 25 1% FC-12 21 Denatured, only terminal residues visible
21 5P12-RANTES-E66S 3.8 60 1% FC-12 21 Denatured, most residues visible
22 5P12-RANTES-E66S 3.8 25 1% DDM, 12 Folded
1% CHAPS, 2.0
0.2% CHS N/A
23 Ubiquitin 4.7 25 — — Folded
24 Ubiquitin 4.7 25 1% FC-12 21 Folded
25 Ubiquitin 4.7 25 1% SDS 21 Denatured, most resonances visible
Effects of detergents on RANTES-E66S, 5P12-RANTES-E66S, and ubiquitin at various buffer, pH, and temperature conditions.
aProtein concentrations were 50 mM.
bBuffers used: 50 mM DCOONa (pH 3.8), 50 mM CD3COONa (pH 4.7), 50 mM DCOONa (pH 6.3), and 50 mM Tris-HCl (pH 8.8).
cFor nomenclature, chemical structures of detergent, and CMC, see Table S1.
dIntensity of monomer (Im) and dimer (Id) resonances in HSQC spectra.
2592 Wiktor et al.affected, suggesting the coexistence of a nativelike and a
detergent-perturbed RANTES-E66S state (see Fig. S6 d).
The reported CMC (see Table S1) of FC-8 is 3.4% and
thus considerably higher than that of FC-10, -12, and -16
(%0.35%). This dependence on concentration shows that,
similar to findings on sodium dodecyl-sulfate (SDS) (61),
Fos-Choline micelle formation is required for effective
RANTES denaturation.
To study the dependence on Fos-Choline concentration in
more detail, we have carried out a titration of 5P12-
RANTES-E66S with FC-12 (37C, pH 3.8). HSQC spectra
show a monotonous decrease of native-state 5P12-
RANTES-E66S resonances with increasing FC-12 concen-
tration (Fig. 7 b and see Fig. S9). The midpoint occurs at
~3 mM (0.1%, i.e., in the vicinity of the CMC). In addition
to the decrease in intensity, small but significant chemical
shift changes are observable (Fig. 7 a), which start well
below the CMC and are monotonous with FC-12 concentra-
tion. A chemical-shift map reveals that the interaction
surface spans an elongated, mostly hydrophobic crevice
between residues C10/C11 and a more polar (positive)
region around residues R22/H23 (Fig. 7, c and d). ThisBiophysical Journal 105(11) 2586–2597surface appears suited to accommodate the FC-12 hydrocar-
bon chain within the hydrophobic crevice and the phospho-
choline headgroup at its polar end. Interestingly, the
hydrophobic crevice also coincides in part with the
RANTES dimer interface harboring residues S4-P9 of
the interacting monomer (Fig. 7 d). The mixed hydropho-
bic/polar RANTES surface perturbed by FC-12 is somewhat
reminiscent of the ubiquitin surface affected by SDS at sub-
CMC concentration (61). In the latter case, many interacting
residues are also hydrophobic, but surface regions with a
positive potential dominate.
All Fos-Choline detergents have a similar denaturing
effect on RANTES above their respective CMC regardless
of the hydrocarbon tail length. However, a change from
Fos-Choline with a single fatty acid chain to DHPC (1,2-
diheptanoyl-sn-glycero-3-phosphocholine) with two fatty
acids chains abolished the denaturing effect. Even at 5%
DHPC (CMC 0.067%) no RANTES denaturation could be
observed (see Fig. S6 i). This indicates that the particular to-
pology of the hydrocarbon tail and/or its connection to the
choline headgroup are crucial for the interaction with
RANTES.
ab
c
d
FIGURE 7 Residue-specific interaction of 5P12-
RANTES-E66S with FC-12 from chemical-shift
mapping. A titration of 0.10 mM 15N-labeled
5P12-RANTES-E66S (50 mM DCOONa pH 3.8)
was carried out with FC-12 at 37C. (a) Weighted
average chemical-shift differences (Ddav ¼ ((DdN2/
25þDdHN2)/2)1/2) for 1.0 mM and 4.5 mM FC-12
relative to no FC-12. Significantly perturbed resi-
dues are marked (>6/4 ppb, orange; and >9/6 ppb,
red). The amino acid sequence of 5P12-RANTES-
E66S is given at the top. (b) Intensities of 5P12-
RANTES-E66S backbone 1H-15N resonances in
the presence of 1.0 and 4.5 mM FC-12 relative to
the intensity without detergent. Residues are colored
as in panel a. (c) Space-filling representation of the
crystal structure PDB:1EQT (one of two monomers)
with chemical-shift map of 5P12-RANTES-E66S
residues significantly perturbed by FC-12 (colored
in red and orange according to panel a). (Cyan)
Positions of proline residues, for which no 1H-15N
resonances can be detected. Residues perturbed by
FC-12 form a continuous stretch across the mole-
cule. (d) Electrostatic surface representation of panel
c. Positive (blue) and negative (red) surface potential
is shown. To reflect the charge distribution at pH 3.8,
residue H23 was assumed in the protonated state.
The second RANTES dimer (green cartoon) oc-
cupies a part of the hydrophobic crevice where FC-
12 binds. Panels c and d were generated using the
software PyMOL (76). To see this figure in color,
go online.
Characterization of 5P12-RANTES 2593In addition to Fos-Cholines, the zwitterionic surfactant
DMG-12 (dodecyl-n,n-dimethylglycine, CMC 0.041%)
also shows a strong effect on RANTES and puts it into a
dark state similar to that of the Fos-Cholines (see
Fig. S6 l). Analogously to FC-12, again many more reso-
nances become visible at higher temperature (see
Fig. S6 m). However, the zwitterionic surfactant ANZ-3-
12 (n-dodecyl-n,n-dimethyl-3-ammonio-1-propanesulfo-
nate, CMC 0.094%), containing an identical dodecyl
hydrocarbon chain, but an ammonium-sulfonate headgroup
and also the positively charged TMA-12 (n-dodecyltrime-thylammonium chloride, CMC 0.03–0.5% (62)), did not
cause RANTES denaturation (see Fig. S6, j and k). Not
surprisingly, the strong, anionic detergent SDS (CMC
0.2%) very efficiently denatures RANTES and bleaches
most resonances (see Fig. S6 n). In contrast, the mild
nonionic detergent Cymal-5 (CMC 0.1%) did not affect
the position and linewidth of the RANTES resonances,
but interestingly shifted the RANTES-E66S monomer-
dimer equilibrium toward the monomeric state (see
Fig. S6 o). The same was observed for the frequently
used (60) GPCR detergent mixture 1% DDM/1%Biophysical Journal 105(11) 2586–2597
2594 Wiktor et al.CHAPS/0.2% CHS (see Fig. S6 p). This shift may be ratio-
nalized by assuming that these detergents interact with
RANTES via the same hydrophobic crevice as FC-12,
and thus block the dimer interaction site.
In summary, all investigated detergents, which denature
RANTES, are fully active only above their CMC and have
a single fatty acid chain in their hydrophobic part. There
is no clear correlation to the type of headgroup: some (phos-
phocholine and dimethylglycine), but not all zwitterionic,
and the investigated negatively charged (SDS) detergent,
were denaturing. The positively charged detergent (n-dode-
cyltrimethylammonium) was not denaturing, which may be
explained by the partially positive interaction surface found
in the FC-12 titration. A further common feature is that all
denaturing detergents (FC-12, DMG-12, SDS) caused rather
similar changes in the HSQC spectra of RANTES, which
may indicate a similar denatured conformational ensemble
in these detergents.
This unfolded state in FC-12 is characterized by a shift to
a more a-helical secondary structure content. The fact that
detergents may affect the conformation of soluble proteins
has been known for over 50 years (63–65). If detergents
have an effect, often all-helical proteins lose, while nonhel-
ical proteins gain helicity (65,66). The changes in secondary
structure usually result from hydrophobic as well as charged
interactions between the polypeptide and the detergent at
concentrations above the CMC (61,67,68). However, for
certain detergents like the anionic SDS, shifts to helical
structure can also be observed below the CMC (61,67,69).
In agreement with our observation, several unfolded or
water-insoluble polypeptides have been shown to increase
their a-helical content in FC-12 (67,69–71). However, for
RANTES the structural transition occurs from a well-
folded, soluble protein.TABLE 2 Summary of 5P12-RANTES-E66S and RANTES-
E66S CD thermal denaturation experiments
RANTES Buffer pH at 20C DH [kcal/mol] Tm [C]
E66S 50 mM HCOONa 3.8 26.9 64.5
E66S 10 mM Na2HPO4 6.3 38.4 75.8
E66S 10 mM Na2HPO4 7.7 37.9 77.5
E66S 50 mM Tris-HCl 8.8a 53.6 73.3
E66S 10 mM NaH2BO3 8.8 48.3 70.4
5P12-E66S 50 mM HCOONa 3.8 24.5 65.5
5P12-E66S 10 mM Na2HPO4 6.3 33.9 77.0
Parameters DH and Tm were derived from fits in Fig. S11.
aBecause for Tris d(pKa)/dT¼0.028, the real pH value at Tm is ~1.5 units
lower than the value measured at room temperature.pH dependence of FC-12-induced RANTES
denaturation and thermal stability
The perturbation of RANTES by FC-12 is most pronounced
at pH 3.8 (see Fig. S6 f), whereas it is only partial at pH 6.3
(see Fig. S6 q), and no perturbation is observed at pH 8.8
(see Fig. S6 s). To exclude that this behavior was caused
by a pH-induced change of FC-12 surface charges, a pH
titration of FC-12 was carried out by adding NaOH (see
Fig. S10). The titration curve is completely flat between
pH 4 and 10, corresponding to a normalized buffering
capacity
1
½FC-12
v½NaOH
vpH
of 0.0065, which indicates that there is no titrable surface
charge on FC-12 in this pH range (72). Hence, the differing
interactions of RANTES and FC-12 at low and high pH
should be attributed to RANTES itself, i.e., to its titratableBiophysical Journal 105(11) 2586–2597surface groups such as the side chains of aspartic and
glutamic acid residues (total 4/3 in RANTES-E66/5P12-
RANTES-E66S) or of its single histidine (H23), which
have pK values in the respective pH range. Indeed, the influ-
ence of the protonation state of H23 on the FC-12 interac-
tion is highly likely due to its location within the
interaction surface (Fig. 7, c and d).
Because the interaction with FC-12 destabilizes the
native structure of RANTES, we asked whether there is
also a correlation with the (thermal) stability of RANTES
at the different pH values. A CD melting experiment (see
Fig. S11 a and Table 2) revealed that RANTES-E66S
has a lower melting temperature (Tm ¼ 64.5C) and
melting enthalpy (DH ¼ 26.9 kcal/mol) at pH 3.8 than at
pH 6.3 and 7.7 (75.8C/38.4 kcal/mol and 77.5C/
37.9 kcal/mol, respectively). Melting temperatures and en-
thalpies at the even higher pH 8.8 had considerable errors,
because Tris significantly changes its pK (and therefore the
pH of the solution) with temperature, while the measure-
ment in borate was jeopardized by protein precipitation.
Nevertheless, the determined values are still higher than
at pH 3.8. Similar increases in melting temperature and
enthalpy at higher pH were observed for 5P12-RANTES-
E66S (see Fig. S11 b and Table 2). Thus both the decrease
in stability and the change to a more positive surface
charge may contribute to the increased susceptibility of
RANTES to Fos-Choline-induced denaturation at low pH
values.Interactions of ubiquitin with FC-12 and SDS
To check whether other proteins are also denatured by Fos-
Choline, we tested the thermostable protein ubiquitin (Tm >
100C (73)). No sign of chemical shift perturbation was
observed in 1% FC-12 (see Fig. S6, w and x), indicating
that this detergent is not strong enough to denature this
extraordinary stable biomolecule. However, consistent
with previous studies (61,74), the stronger detergent SDS
caused denaturation at 1% concentration, as evident by a
strong reduction of dispersion in the backbone 1HN reso-
nances (see Fig. S6 y).
Characterization of 5P12-RANTES 2595CONCLUSION
This study presents a biophysical characterization of the
nonaggregating E66S mutant of the microbicide candidate
5P12-RANTES. In contrast, to wt-RANTES, 5P12-
RANTES-E66S (and also 5P12-RANTES) is unable to
dimerize up to millimolar concentrations, apparently as a
result of its mutated N-terminus, which is highly flexible
on the nanosecond timescale and unable to form an intermo-
lecular b-sheet. The remainder of the tertiary structure
beyond residue C10 is very similar to wt-RANTES.
We have also analyzed the behavior of 5P12-RANTES-
E66S and RANTES-E66S in the presence of various deter-
gents. The zwitterionic surfactants, i.e., Fos-Cholines and
DMG-12, as well as the anionic SDS, denature RANTES
above their CMC at low pH. The nonionic Cymal-5, the
zwitterionic ANZ-3-12, and DHPC, the positively charged
TMA-12, and the lipid/detergent mixture DDM/CHAPS/
CHS cause only moderate (shift in monomer/dimer
equilibrium) or no effects. A more detailed analysis of the
FC-12-induced denaturation showed that the interaction
starts below CMC within a hydrophobic crevice that is
delimited on one side by a positively charged surface patch.
This hydrophobic crevice overlaps in part with the dimeri-
zation interface. Higher FC-12 concentrations induce
RANTES denaturation to a state with a slightly extended
native a-helix and two further regions with a-helical
propensities of ~25%. We have also observed that at
neutral pH, RANTES is more stable than at low pH against
thermal as well as FC-12-induced denaturation. This pH
dependence must be linked to changes in the RANTES
surface charge and may in particular be connected to the
titration of residue H23, which is part of the FC-12 inter-
action surface.
In summary, we have characterized the structure, dy-
namics, detergent interactions, and other properties of the
anti-HIV microbicide 5P12-RANTES. These data should
help to better understand its physicochemical behavior,
choose suitable detergents for interaction studies with
CCR5, and provide general insights into the mechanism of
detergent denaturation of soluble proteins.SUPPORTING MATERIAL
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